China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 3,220 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.
Follow-Up Questions
CSWYY 주식의 가격 성능은 어떻습니까?
CSWYY의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
China Shineway Pharmaceutical Group Ltd의 주요 사업 주제나 업종은 무엇입니까?
China Shineway Pharmaceutical Group Ltd은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
China Shineway Pharmaceutical Group Ltd의 시가총액은 얼마입니까?
China Shineway Pharmaceutical Group Ltd의 현재 시가총액은 $0입니다
China Shineway Pharmaceutical Group Ltd는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 7명의 분석가가 China Shineway Pharmaceutical Group Ltd에 대한 분석 평가를 실시했으며, 이는 3명의 강력한 매수, 3명의 매수, 1명의 보유, 0명의 매도, 그리고 3명의 강력한 매도를 포함합니다